Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Beta Bionics Inc shares valued at $209,151 were sold by Feider Stephen on Sep 08 ’25. At $21.13 per share, Feider Stephen sold 9,900 shares. The insider’s holdings dropped to 44,041 shares worth approximately $1.12 million following the completion of this transaction.
Also, Hopman Mark sold 11,411 shares, netting a total of over 234,657 in proceeds. Following the sale of shares at $20.56 each, the insider now holds 31,215 shares.
Before that, Hopman Mark had sold 6,818 shares from its account. In a trade valued at $136,180, the Chief Commercial Officer traded Beta Bionics Inc shares for $19.97 each. Upon closing the transaction, the insider’s holdings decreased to 6,818 shares, worth approximately $0.79 million.
As published in their initiating research note from Truist on June 16, 2025, Beta Bionics Inc [BBNX] has been a Buy and the price target has been revised to $26. Analysts at Lake Street started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of May 30, 2025, Wolfe Research has initiated its “an Outperform” rating for BBNX. Earlier on May 30, 2025, Goldman initiated its rating. Their recommendation was “a Neutral” for BBNX stock.
Analyzing BBNX Stock Performance
On last trading session, Beta Bionics Inc [NASDAQ: BBNX] rose 1.89% to $25.34. The stock’s lowest price that day was $24.41, but it reached a high of $25.63 in the same session. During the last five days, there has been a surge of approximately 26.07%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 24.62, which, if violated, would cause prices to drop to 23.91. In the upper region, resistance lies at 25.84. The next price resistance is at 26.35. RSI (Relative Strength Index) is 83.55 on the 14-day chart, showing overbought technical sentiment.
Is Beta Bionics Inc subject to short interest?
Stocks of Beta Bionics Inc saw a sharp steep in short interest on 2025-08-29 dropping by -1.08 million shares to 3.11 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 4.19 million shares. A decline of -34.62% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.22 of the overall float, the days-to-cover ratio (short ratio) decline to 4.22.
Which companies own the most shares of Beta Bionics Inc (BBNX)?
In terms of Beta Bionics Inc share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, down nearly -31.64% from the previous closing price of $24.87. Analysts anticipate Beta Bionics Inc stock to reach 17 by 2025, with the lowest price target being 17. On February 24, 2025, Stifel assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
